1. Performance measures for ERCP and endoscopic ultrasound: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
- Author
-
Thierry Ponchon, Gianpiero Manes, Jan Werner Poley, Cesare Hassan, Andrea Tringali, Tibor Gyökeres, Michal F. Kaminski, Cristiano Spada, Cathy Bennett, Dirk Domagk, Silvia Minozzi, Colin J Rees, Roland Valori, Raf Bisschops, Michael Bretthauer, Mário Dinis-Ribeiro, Matthew D. Rutter, Kofi Oppong, Carlo Senore, Lars Aabakken, Cristina Bellisario, Peter Meier, László Czakó, and Gastroenterology & Hepatology
- Subjects
Endoscopic ultrasound ,medicine.medical_specialty ,Performance measures ,Biopsy ,Settore MED/18 - CHIRURGIA GENERALE ,Gallstones ,Catheterization ,Endosonography ,03 medical and health sciences ,ERCP ,0302 clinical medicine ,medicine ,Humans ,Antibiotic prophylaxis ,EUS ,Quality Indicators, Health Care ,Cholangiopancreatography, Endoscopic Retrograde ,Common Bile Duct ,Endoscopic retrograde cholangiopancreatography ,Common bile duct ,medicine.diagnostic_test ,Bile duct ,business.industry ,General surgery ,Gastroenterology ,Guideline ,Antibiotic Prophylaxis ,medicine.disease ,Quality Improvement ,digestive system diseases ,Endoscopy ,medicine.anatomical_structure ,Pancreatitis ,030220 oncology & carcinogenesis ,Stents ,030211 gastroenterology & hepatology ,business - Abstract
The European Society of Gastrointestinal Endoscopy and United European Gastroenterology present a short list of key performance measures for endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP). We recommend that endoscopy services across Europe adopt the following seven key and one minor performance measures for EUS and ERCP, for measurement and evaluation in daily practice at center and endoscopist level: 1 Adequate antibiotic prophylaxis before ERCP (key performance measure, at least 90 %); 2 Antibiotic prophylaxis before EUS-guided puncture of cystic lesions (key performance measure, at least 95 %); 3 Bile duct cannulation rate (key performance measure, at least 90 %); 4 Tissue sampling during EUS (key performance measure, at least 85 %); 5 Appropriate stent placement in patients with biliary obstruction below the hilum (key performance measure, at least 95 %); 6 Bile duct stone extraction (key performance measure, at least 90 %); 7 Post-ERCP pancreatitis (key performance measure, less than 10 %). 8 Adequate documentation of EUS landmarks (minor performance measure, at least 90 %).This present list of quality performance measures for ERCP and EUS recommended by ESGE should not be considered to be exhaustive: it might be extended in future to address further clinical and scientific issues.
- Published
- 2018